Your browser doesn't support javascript.
loading
Indocyanine green clearance tests to assess liver transplantation outcomes: a systematic review.
Caimano, Miriam; Bianco, Giuseppe; Coppola, Alessandro; Marrone, Giuseppe; Agnes, Salvatore; Lai, Quirino; Spoletini, Gabriele.
Afiliação
  • Caimano M; General Surgery and Liver Transplantation, Fondazione Policlinico Universitario Agostino Gemelli IRCCS.
  • Bianco G; General Surgery and Liver Transplantation, Fondazione Policlinico Universitario Agostino Gemelli IRCCS.
  • Coppola A; General Surgery and Liver Transplantation, Fondazione Policlinico Universitario Agostino Gemelli IRCCS.
  • Marrone G; Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
  • Agnes S; General Surgery and Liver Transplantation, Fondazione Policlinico Universitario Agostino Gemelli IRCCS.
  • Lai Q; Policlinico Umberto I, Sapienza University of Rome, Rome, Italy.
  • Spoletini G; General Surgery and Liver Transplantation, Fondazione Policlinico Universitario Agostino Gemelli IRCCS.
Int J Surg ; 110(1): 431-440, 2024 Jan 01.
Article em En | MEDLINE | ID: mdl-37800567
ABSTRACT

BACKGROUND:

Liver transplantation (LT) is the gold standard for end-stage liver disease, yet postoperative complications challenge patients and physicians. Indocyanine green (ICG) clearance, a quantitative dynamic test of liver function, is a rapid, reproducible, and reliable test of liver function. This study aimed to systematically review and summarize current literature analyzing the association between ICG tests and post-LT outcomes.

METHODS:

This systematic review was conducted according to PRISMA guidelines. MEDLINE and Cochrane Library, as main databases, and other sources were searched until August 2022 to identify articles reporting the prognostic value of postoperative ICG tests associated with outcomes of adult LT recipients.Risk of bias of included articles was assessed using Quality In Prognosis Studies tool. Methodological quality varied from low to high across risk of bias domains.

RESULTS:

Six studies conducted between 1994 and 2018 in Europe, America, and Asia were included. The study population ranged from 50 to 332 participants. ICG clearance on the first postoperative day was associated with early allograft dysfunction, graft loss, 1-month and 3-month patient survival probability, prolonged ICU, and hospital stay. The dichotomized ICG plasma disappearance rate (PDR) provided a strong association with medium-term and long-term

outcomes:

PDR less than 10%/min with 1-month mortality or re-transplantation (odds ratio 7.89, 95% CI 3.59-17.34, P <0.001) and PDR less than 16.0%/min with 3-month patient survival probability (hazard ratio 13.90, 95% CI 4.67-41.35, P <0.01). The preoperative model for end-stage liver disease and body mass index were independent prognostic factors for early allograft dysfunction, early complications, and prolonged ICU stay; post-LT prothrombin time and INR were independently associated with graft loss and bilirubin with a prolonged hospital stay.

CONCLUSION:

This review shows that ICG clearance tests are associated with graft function recovery, suggesting that a potential prognostic role of ICG test, as an aid in predicting the post-LT course, could be considered.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Doença Hepática Terminal Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Adult / Humans Idioma: En Revista: Int J Surg Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Doença Hepática Terminal Tipo de estudo: Prognostic_studies / Systematic_reviews Limite: Adult / Humans Idioma: En Revista: Int J Surg Ano de publicação: 2024 Tipo de documento: Article